Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Not yet recruiting × NIH × Clear all

Phase

Phase 2 8 Phase 1/2 7 Phase 1 5 Phase NA 1 Phase 3 1 Phase 2/3 1

Status

Completed 216 Unknown 145 Active not recruiting 51 Terminated 16 Recruiting 13 Suspended 2 Withdrawn 1 Not yet recruiting 1

Sponsor Class

OTHER 191 INDUSTRY 87 OTHER_GOV 12 NETWORK 7 NIH 1 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

atezolizumab 1 Watchful Waiting 1 Specimen Handling 1 Observation 1 Hyaluronoglucosaminidase 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07388524 2026-03-17

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

National Cancer Institute (NCI)

Phase 3 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡